A federal advisory committee recommended Tuesday that a fourth COVID-19 vaccine be authorized for use in the USA, this one from Novavax, a company based in Gaithersburg, Maryland. https://www.usatoday.com/story/news/health/2022/06/07/novavax-covid-vaccine-recommended-fda-panel-use-us/7542891001/